Identification Of Genetic and Epigenetic Alterations In Spondyloarthritis

Tibor A Rauch, Beata Tryniszewska, Andras Vida, Timea Ocsko, Sandor Szanto, Holly L Rosenzweig, Matthew A Brown, Gethin P Thomas, Katalin Mikecz, Tibor T Glant

    Research output: Other contribution to conferenceAbstractpeer-review


    Ankylosing spondylitis (AS) is the prototypic spondyloarthritis and affects approximately 0.2-0.5% of the human population. It is estimated that genetic risk factors contribute >90% of disease susceptibility, and the major genetic risk factor is HLA-B27. Approximately the other half of the genetic risk is composed by non-MHC traits. By generating interval-specific congenic (IVSC) strains utilizing the genetic combination of proteoglycan-induced SpA (PGISpA) in susceptible BALB/c mice and SpA-resistant DBA/2 mice (both carry the same MHC) we can identify non-MHC causative genes by excluding the effect of the MHC. These IVSC strains with overlapping chromosome (Chr) regions were used to narrow the (Pgis2) risk locus on mouse Chr2 (mChr2) to a small region syntenic with AS risk loci on human chromosomes 4 and 9.
    Original languageEnglish
    Number of pages1
    Publication statusPublished - 2013
    Event2013 ACR/ARHP Annual Meeting - San Diego, United States
    Duration: 24 Oct 201329 Oct 2013


    Conference2013 ACR/ARHP Annual Meeting
    Country/TerritoryUnited States
    CitySan Diego
    Internet address


    Dive into the research topics of 'Identification Of Genetic and Epigenetic Alterations In Spondyloarthritis'. Together they form a unique fingerprint.

    Cite this